Carbohydrates, glycans, and their conjugates play critical roles in a very broad
spectrum of biological processes, many of which are central to human health,
development and disease states. The diversity of glycan-dependent biological
processes is reflected by the even-more diverse spectrum and complexity of the
implicated glycans and glycoconjugates, collectively known as the glycome. The study
of glycan dependent biological processes and their eventual regulation and/or
exploitation in human medicine is enormously hampered by difficulties in isolating and
structurally characterizing meaningful quantities of pure unique glycans, known as
homogeneous glycoforms, from biological sources. It is imperative therefore that simple
practical technologies for glycan synthesis be developed that combine robustness with
ease of operation such that specialist and non-specialists alike will be able to access
glycans with relative ease. This proposal aims to develop exactly the kind of scalable
robust methodology that is required to address the chemical synthesis of a broad cross
section of the glycome. The focus is on the development of direct photochemical
methods without the need for external additives thereby reducing the system to its
essentials – a glycosyl donor and glycosyl acceptor – and eliminating complexity to the
greatest extent possible. The technologies to be developed are designed to employ
light-emitting diodes (LEDs) as light sources and ultimately to be applicable under flow
conditions so as to enable practical scaled-up syntheses of biologically important
glycans.
Public Health Relevance Statement
The state-of-the-art in practical efficient and stereocontrolled preparation of glycosidic
bonds lags far behind that for peptide and oligonucleotide synthesis and consequently
seriously hinders the study of the biology of oligosaccharides and their conjugates. This
proposal sets out two develop two new photochemical technologies for glycosidic bond
formation, with the emphasis on simplicity and ease of operation such as will be required
if synthetic glycans are to be made routinely available to the Glycoscience community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAlcoholsAnionsBiologicalBiological ProcessBiologyCarbohydratesCationsChemistryCommunitiesDevelopmentDiseaseEstersFluoridesGlycoconjugatesGlycolsGlycosidesGoalsHealthHumanIonsLightMedicineMethodologyMethodsOligonucleotidesOligosaccharidesPeptidesPlayPolysaccharidesPreparationProtocols documentationReactionReagentRegulationReproducibilityRoleSourceSpecialistSystemTechnologyTestingcatalystchemical synthesisdesignglycosylationimprovedinnovationirradiationlight emissionnew technologynovelnucleophilic substitutionoperationpromoterscale up
No Sub Projects information available for 5R21GM149588-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21GM149588-02
Patents
No Patents information available for 5R21GM149588-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21GM149588-02
Clinical Studies
No Clinical Studies information available for 5R21GM149588-02
News and More
Related News Releases
No news release information available for 5R21GM149588-02
History
No Historical information available for 5R21GM149588-02
Similar Projects
No Similar Projects information available for 5R21GM149588-02